iPSC Differentiation to Cardiomyocytes | Applied StemCell
![](https://pinchforthtesting.com/wp-content/uploads/2024/04/bg23.png)
“
We provide top-quality service for the directed differentiation of iPSCs into cardiomyocytes using our efficient induction protocol and reagents. We deliver ready-to-use, functional ventricular and atrial cardiomyocytes that are desirable
in vitro
models for high-content toxicity and drug screening, and cell regeneration research. We deliver receive feasible and physiologically relevant alternatives to embryonic stem cells, primary cells, and animal models.
- High-quality atrial and ventricular cardiomyocytes
- Biomarkers:
-
cTNT, alpha-SMA, MLC2A, and MLC2V; video of beating cells
-
- We can generate differentiated cardiomyocytes from iPSC derived from healthy or disease patient samples
- Fast turnaround:
2 weeks
-
GMP iPSC Differentiation Services Available >> Learn More
Get iPSCs to genetically modify and further differentiate into immune cells? We offer fully customizable
iPSC generation
from human or non-human tissue samples, and our genome editing experts can use
CRISPR or TARGATT™ to genetically alter the iPSCs
to fit your project requirements. If you need to expedite your experimental timeline, ASC also offers off-the-shelf
cardiomyocytes
. Contact us today to find the best solution for your projects.
Beating iPSC-Derived Cardiomyocytes – Video 1| Applied StemCell, Inc.
Beating iPSC-Derived Cardiomyocytes – Video 2 | Applied StemCell, Inc.
“